Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1142-1146

  Imai, Atsushi ^a   Takagi, Atsushi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Endometriosis; Endometrium; Gonadotropin releasing hormone analog

Indexed keywords

BUSERELIN; DNA FRAGMENT; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; HOE 33342; LEUPRORELIN; PROPIDIUM IODIDE;

ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0034123428     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.104804     Document Type: Article

References (23)

1. 1. Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. Apoptosis in human endometrial and endometriotic tissues. Horm Res 1997;48 Suppl 3:42-7.
2. 2. Braun D, Dmowski W. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 1998;10:365-9.
3. 3. Gebel H, Braun D, Tambur A, Frame D, Rana N, Dmowski P. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis Fertil Steril 1998;69:1042-7.
4. 4. Chatzaki E, Bax C, Eidne K, Anderson L, Grudzinskas J, Gallagher C. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Res 1996;56:2059-65.
5. 5. Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Gonadotropin-releasing hormone receptor in gynecologic tumors: frequent expression in adenocarcinoma histologic types. Cancer 1994;74:2555-61.
6. 6. Janovick J, Conn P. Gonadotropin releasing hormone agonist provokes homologous receptor microaggregation: an early event in seven-transmembrane receptor mediated signaling. Endocrinology 1996;137:3602-5.
7. 7. Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers. Hum Reprod Update 1994;9:1364-79.
8. 8. Imai A, Horibe S, Takagi H, Fuseya T, Tamaya T. Signal transduction of GnRH receptor in the reproductive tract tumor. Endocr J 1996;43:249-60.
9. 9. Ackerman R, Johnson G, Van Kirk E, Asirvatham A, Murdoch W. Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide. Cancer Lett 1994;81:177-84.
10. 10. Ghahremani M, Foghi A, Dorrington J. Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism. Gynecol Oncol 1998;70:275-81.
11. 11. Kleinman D, Douvdevani A, Schally A, Levy J, Sharoni Y. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releashig hormone antagonist SB-75: role of apoptosis. Am J Obstet Gynecol 1994;170:96-102.
12. 12. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
13. 13. The American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43:351-2.
14. 14. Imai A, Horibe S, Takagi A, Ohno T, Tamaya T. Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors. Eur J Obstet Gynecol Reprod Biol 1997;74:73-8.
15. 15. Imai A, Takagi H, Furui T, Horibe S, Fuseya T, Tamaya T. Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane. Cancer 1996;77:132-7.
16. 16. Allen R, Hunter WI, Agrawal D. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods 1997;37:215-28.
17. 17. Harada M, Suganuma N, Furuhashi M, Nagasaka T, Nakashima N, Kikkawa F, et al. Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 1996;2:307-15.
18. 18. Hopwood D, Levison D. Atrophy and apoptosis in the cyclical human endometrium. J Pathol 1976;119:159-66.
19. 19. Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Keneko Y, et al. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 1997;176:360-8.
20. 20. Hetts S. To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998;279:300-7.
21. 21. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
22. 22. Imai A, Takagi A, Horibe S, Takagi H, Tamaya T. Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells. Int J Oncol 1998;13:97-100.
23. 23. Imai A, Takagi A, Horibe S, Takagi H, Tamaya T. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. J Clin Endocrinol Metab 1998;83:427-31.